Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof
US12233111B2 · kind B2 · utility
2Cited by
54References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2024 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Feb 16, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds having the structure of Formula Ia, wherein the compounds comprise a therapeutic agent having the sequence of SEQ ID NO: 35, and the compounds have an anion:cation molar ratio of from about 1:1 to about 1:7, and methods of using thereof for the treatment of metabolic diseases or disorders, including type 1 diabetes, type 2 diabetes, obesity, overweight, and nonalcoholic steatohepatitis, and for reducing weight in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.